These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24584995)

  • 21. CHA2DS2-VASc and HAS-BLED scores and activated partial thromboplastin time for prediction of high plasma concentration of dabigatran at trough.
    Owada S; Tomita H; Kinjo T; Ishida Y; Itoh T; Sasaki K; Horiuchi D; Kimura M; Sasaki S; Okumura K
    Thromb Res; 2015 Jan; 135(1):62-7. PubMed ID: 25466835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in anticoagulation: focus on dabigatran, an oral direct thrombin inhibitor.
    Augoustides JG
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):1208-12. PubMed ID: 21982327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stroke thrombolysis in patients taking dabigatran.
    Jayathissa S; Gommans J; Harper P
    Intern Med J; 2013 Jul; 43(7):826-8. PubMed ID: 23841763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coronary embolization following electrical cardioversion in a patient treated with dabigatran.
    Gagliardi L; Guerbaai RA; Marlière S; Bouvaist H; Ennezat PV
    Int J Cardiol; 2014 Aug; 175(3):571-2. PubMed ID: 24861253
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of acute stroke in patients on dabigatran: a survey of US stroke specialists.
    Rybinnik I; Mullen MT; Messe S; Kasner SE; Cucchiara B
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1312-6. PubMed ID: 23313461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Dabigatran as cause of severe gastrointestinal bleeding in a Jehovah's Witness patient].
    Holm J; Taskiran M
    Ugeskr Laeger; 2013 Feb; 175(6):334-6. PubMed ID: 23402236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endovascular thrombectomy for acute ischemic stroke patients anticoagulated with dabigatran.
    Müller P; Topakian R; Sonnberger M; Nußbaumer K; Windpessl M; Eder V; Nesser HJ; Trenkler J; Haring HP
    Clin Neurol Neurosurg; 2013 Oct; 115(10):2257-9. PubMed ID: 23921437
    [No Abstract]   [Full Text] [Related]  

  • 28. Dabigatran assessment in patients with acute complications using routine coagulation assays.
    Stang L; Nahirniak S; Butcher K; Szkotak AJ
    Blood Coagul Fibrinolysis; 2014 Jul; 25(5):426-34. PubMed ID: 24637695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Good outcome after intravenous thrombolysis for acute stroke in a patient under treatment with dabigatran.
    Diogo C; Duarte J; Sobral S; Pestana P; Nzwalo H; Rita H; Sousa E Costa J
    Am J Emerg Med; 2014 Nov; 32(11):1435.e1-2. PubMed ID: 24881517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential inaccuracy of point-of-care INR in dabigatran-treated patients.
    Baruch L; Sherman O
    Ann Pharmacother; 2011 Jul; 45(7-8):e40. PubMed ID: 21712509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemostatic therapy in experimental intracerebral hemorrhage associated with the direct thrombin inhibitor dabigatran.
    Zhou W; Schwarting S; Illanes S; Liesz A; Middelhoff M; Zorn M; Bendszus M; Heiland S; van Ryn J; Veltkamp R
    Stroke; 2011 Dec; 42(12):3594-9. PubMed ID: 21998060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of dabigatran-associated intracerebral and intraventricular hemorrhage: a case report.
    Faust AC; Peterson EJ
    J Emerg Med; 2014 Apr; 46(4):525-9. PubMed ID: 24508114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemorrhagic complications in emergency department patients who are receiving dabigatran compared with warfarin.
    Berger R; Salhanick SD; Chase M; Ganetsky M
    Ann Emerg Med; 2013 Apr; 61(4):475-9. PubMed ID: 23522810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dabigatran bleed risk with closed head injuries: are we prepared?
    Parra MW; Zucker L; Johnson ES; Gullett D; Avila C; Wichner ZA; Kokaram CR
    J Neurosurg; 2013 Sep; 119(3):760-5. PubMed ID: 23634730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute ischemic stroke treated with intravenous tissue plasminogen activator in a patient taking dabigatran with radiographic evidence of recanalization.
    Sangha N; El Khoury R; Misra V; Lopez G
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):917.e5-8. PubMed ID: 22683118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bleeding events and activated partial thromboplastin time with dabigatran in clinical practice.
    Kawabata M; Yokoyama Y; Sasano T; Hachiya H; Tanaka Y; Yagishita A; Sugiyama K; Nakamura T; Suzuki M; Isobe M; Hirao K
    J Cardiol; 2013 Aug; 62(2):121-6. PubMed ID: 23680005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with dabigatran.
    De Smedt A; De Raedt S; Nieboer K; De Keyser J; Brouns R
    Cerebrovasc Dis; 2010; 30(5):533-4. PubMed ID: 20881383
    [No Abstract]   [Full Text] [Related]  

  • 38. What is the role of hemodialysis for dabigatran-associated major bleeding?
    Kim B; Garcia DA
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):514-7. PubMed ID: 25696903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The old and new: PCCs, VIIa, and long-lasting clotting factors for hemophilia and other bleeding disorders.
    Ragni MV
    Hematology Am Soc Hematol Educ Program; 2013; 2013():44-51. PubMed ID: 24319161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversal of dabigatran effects in models of thrombin generation and hemostasis by factor VIIa and prothrombin complex concentrate.
    Hoffman M; Volovyk Z; Monroe DM
    Anesthesiology; 2015 Feb; 122(2):353-62. PubMed ID: 25502064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.